BT-20

From WikiMD's Food, Medicine & Wellnesspedia

For the BT-20 tank, see BT tank.

BT-20 is a breast cancer cell line derived from a 74-year-old human female in 1958 by E.Y. Lasfargues and L. Ozzello.[1] The cells technically came from a triple-negative breast cancer, which was caused by an invasive ductal carcinoma in the mammary gland. BT-20 cells are known to have amplified regions of chromosomes 6, 11, and 20, with most cells being hyperdiploid.[2] The cells express an estrogen receptor with a deletion of exon 5, and are used in preclinical studies of breast cancer.

References[edit | edit source]

  1. ↑
  2. ↑ "BT20". pawefish.uk. Retrieved 10 April 2018.

External links[edit | edit source]


Stub icon

This oncology article is a stub. You can help WikiMD by expanding it.

‎

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Retrieved from "https://wikimd.com/w/index.php?title=BT-20&oldid=5180926"

Contributors: Prab R. Tumpati, MD